Larimar Therapeutics prices $100 million stock offering at $5 per share Feb 25, 2026 08:59PM
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering Feb 25, 2026 08:59PM
Larimar Therapeutics closes $69 million stock offering Jul 31, 2025 04:15PM
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares Jul 31, 2025 04:15PM
Larimar Therapeutics prices $60 million stock offering at $3.20 per share Jul 29, 2025 11:50PM


Jul 29, 2025 11:50PM Larimar Therapeutics Announces Pricing of Underwritten Public Offering
Sep 16, 2022 01:00PM Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares
Sep 14, 2022 07:04AM Larimar Therapeutics (LRMR) Announces $70 Million Underwritten Offering of Common Stock
Sep 14, 2022 07:04AM Larimar Therapeutics Announces $70 Million Underwritten Offering
Jul 8, 2021 04:01PM Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021
May 21, 2021 09:19AM Larimar Therapeutics (LRMR) Announces $95 Million Private Placement Financing of Common Stock, Warrants
May 21, 2021 09:18AM Larimar Therapeutics Announces $95 Million Private Placement Financing